Abstract:The low water solubility of pharmacoactive molecules limits their pharmacological potential, but the solubility parameter cannot compromise, and so different approaches are employed to enhance their bioavailability. Pharmaceutically active molecules with low solubility convey a higher risk of failure for drug innovation and development. Pharmacokinetics, pharmacodynamics, and several other parameters, such as drug distribution, protein binding and absorption, are majorly affected by their solubility. Among all pharmaceutical dosage forms, oral dosage forms cover more than 50%, and the drug molecule should be water-soluble. For good therapeutic activity by the drug molecule on the target site, solubility and bioavailability are crucial factors. The pharmaceutical industry's screening programs identified that around 40% of new chemical entities (NCEs) face various difficulties at the formulation and development stages. These pharmaceuticals demonstrate less solubility and bioavailability. Enhancement of the bioavailability and solubility of drugs is a significant challenge in the area of pharmaceutical formulations. According to the Classification of Biopharmaceutics, Class II and IV drugs (APIs) exhibit poor solubility, lower bioavailability, and less dissolution. Various technologies are discussed in this article to improve the solubility of poorly water-soluble drugs, for example, the complexation of active molecules, the utilization of emulsion formation, micelles, microemulsions, cosolvents, polymeric micelle preparation, particle size reduction technologies, pharmaceutical salts, prodrugs, the solid-state alternation technique, soft gel technology, drug nanocrystals, solid dispersion methods, crystal engineering techniques and nanomorph technology. This review mainly describes several other advanced methodologies for solubility and bioavailability enhancement, such as crystal engineering, micronization, solid dispersions, nano sizing, the use of cyclodextrins, solid lipid nanoparticles, colloidal drug delivery systems and drug conjugates, referring to a number of appropriate research reports.

[Lead compound optimization strategy (3)--Structure modification strategies for improving water solubility].

Innovative medicinal chemistry strategies for enhancing drug solubility

Strategies to Obtain Encapsulation and Controlled Release of Small Hydrophilic Molecules

Improving solubility of poorly water-soluble drugs by protein-based strategy: A review

Drug complexes: Perspective from Academic Research and Pharmaceutical Market

Drug-drug co-amorphous systems: An emerging formulation strategy for poorly water-soluble drugs

A New Strategy to Design Isostructural Salts: the Case of the Antitumor Drug Dimethylaminomicheliolide

Analysis and optimization of drug solubility to improve pharmacokinetics

Advancement in Solubilization Approaches: A Step towards Bioavailability Enhancement of Poorly Soluble Drugs

Is prodrug design an approach to increase water solubility?

Editorial: Persistent Endeavors for the Enhancement of Dissolution and Oral Bioavailability

Recent Advances in Enhancement of Dissolution and Supersaturation of Poorly Water-Soluble Drug in Amorphous Pharmaceutical Solids: A Review

Pharmaceutical approaches for enhancing solubility and oral bioavailability of poorly soluble drugs

Improvement in solubility of poor water-soluble drugs by solid dispersion

Recent advances on aqueous solubility prediction.

Drug design strategies that aim to improve the low solubility and poor bioavailability conundrum in quercetin derivatives

Pharmaceutical Methods for Enhancing the Dissolution of Poorly Water-Soluble Drugs

Nanonization strategies for poorly water-soluble drugs.

Mechanistic Investigation of Drug Supersaturation in the Presence of Polysorbates as Solubilizing Additives by Solution Nuclear Magnetic Resonance Spectroscopy

Counter‐intuitive discovery in the formulation of poorly water‐soluble drugs: Amorphous small‐molecule gels

Bioavailability Enhancement Techniques for Poorly Aqueous Soluble Drugs and Therapeutics